[癌症患者的药理性疼痛管理]
Anke Mütherig1,2, Gesine Scheffler3, Ulrich S Schuler4,5
1Palliativ-Zentrum, Universitätsklinikum Carl Gustav Carus Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland.
Urologie (Heidelberg, Germany)
|April 10, 2024
概括
癌症疼痛管理指南各不相同,质疑世界卫生组织 (WHO) 止痛药梯. 本综述涵盖了非阿片类止痛药的风险,免疫疗法相互作用,以及改善患者护理的实用管理策略.
科学领域:
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前癌症患者的药理性疼痛治疗依赖于指导方针建议.
- 这些指南因证据权重不同而存在差异,影响治疗的一致性.
研究的目的:
- 讨论癌症疼痛管理当前的问题.
- 批判性地评估世界卫生组织 (WHO) 止痛药梯和相关证据.
- 突出止痛药的使用风险和实际考虑.
主要方法:
- 审查当前的文献和指导方针建议.
- 讨论特定药物类别,包括非阿片类止痛药和阿片类药物.
- 考虑实用方面,如药物交互和药物相互作用.
主要成果:
- 世卫组织止痛阶梯的意义,特别是第二阶段和第三阶段之间的区别,日益受到质疑.
- 非阿片类止痛药,如白醇和NSAIDs具有风险,特别是在老年癌症患者中.
- 降醇可能会降低免疫疗法的有效性.
结论:
- 需要更新和协调癌症疼痛管理的指南.
- 仔细考虑止痛药的风险至关重要,特别是在脆弱人群中和与免疫疗法结合时.
- 药物管理的实际方面需要注意,以有效控制疼痛.
相关概念视频
Analgesia and Pain Management
614
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
246
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
246
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
274
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
274
Opioid Analgesics: Synthetic and Semisynthetic Opioids
287
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
198
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
198


